1210809

Samuel N. Lederman, M.D. — FEI 3010160490

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 21, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Palm Springs, FL (United States)

Additional Details

Clinical Investigator (CI)